Sharon-Lise T Normand

Author PubWeight™ 361.75‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Screening for serious mental illness in the general population. Arch Gen Psychiatry 2003 15.75
2 Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 2014 10.54
3 Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation 2009 8.11
4 An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes 2008 6.00
5 Patterns of hospital performance in acute myocardial infarction and heart failure 30-day mortality and readmission. Circ Cardiovasc Qual Outcomes 2009 5.66
6 Pay for performance in commercial HMOs. N Engl J Med 2006 5.52
7 An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with an acute myocardial infarction. Circulation 2006 5.35
8 National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA 2011 5.16
9 Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA 2006 5.06
10 Use of cardiac rehabilitation by Medicare beneficiaries after myocardial infarction or coronary bypass surgery. Circulation 2007 4.74
11 An administrative claims model suitable for profiling hospital performance based on 30-day mortality rates among patients with heart failure. Circulation 2006 4.52
12 The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg 2009 4.39
13 Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA 2010 4.36
14 Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA 2009 4.24
15 Physician clinical performance assessment: prospects and barriers. JAMA 2003 4.16
16 Recent national trends in readmission rates after heart failure hospitalization. Circ Heart Fail 2009 3.95
17 Reader's guide to critical appraisal of cohort studies: 2. Assessing potential for confounding. BMJ 2005 3.94
18 Behavioral health insurance parity for federal employees. N Engl J Med 2006 3.77
19 Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med 2007 3.71
20 Variability in the measurement of hospital-wide mortality rates. N Engl J Med 2010 3.65
21 The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009 3.45
22 Standards for statistical models used for public reporting of health outcomes: an American Heart Association Scientific Statement from the Quality of Care and Outcomes Research Interdisciplinary Writing Group: cosponsored by the Council on Epidemiology and Prevention and the Stroke Council. Endorsed by the American College of Cardiology Foundation. Circulation 2005 3.38
23 Recent declines in hospitalizations for acute myocardial infarction for Medicare fee-for-service beneficiaries: progress and continuing challenges. Circulation 2010 3.32
24 An administrative claims measure suitable for profiling hospital performance based on 30-day all-cause readmission rates among patients with acute myocardial infarction. Circ Cardiovasc Qual Outcomes 2011 3.31
25 Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease. Circulation 2013 3.30
26 Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008 3.29
27 Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study. Stat Med 2007 3.20
28 Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv 2002 3.15
29 Nonemergency PCI at hospitals with or without on-site cardiac surgery. N Engl J Med 2013 2.98
30 Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med 2009 2.96
31 Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ 2006 2.71
32 Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement. Health Aff (Millwood) 2007 2.62
33 Quality measurement in adult cardiac surgery: part 1--Conceptual framework and measure selection. Ann Thorac Surg 2007 2.60
34 Quality measurement in adult cardiac surgery: part 2--Statistical considerations in composite measure scoring and provider rating. Ann Thorac Surg 2007 2.59
35 Regionalization and the underuse of angiography in the Veterans Affairs Health Care System as compared with a fee-for-service system. N Engl J Med 2003 2.57
36 Comparison of clinical and administrative data sources for hospital coronary artery bypass graft surgery report cards. Circulation 2007 2.55
37 Cardiac rehabilitation and survival in older coronary patients. J Am Coll Cardiol 2009 2.45
38 Reader's guide to critical appraisal of cohort studies: 1. Role and design. BMJ 2005 2.43
39 Massachusetts cardiac surgery report card: implications of statistical methodology. Ann Thorac Surg 2005 2.40
40 National patterns of risk-standardized mortality and readmission for acute myocardial infarction and heart failure. Update on publicly reported outcomes measures based on the 2010 release. Circ Cardiovasc Qual Outcomes 2010 2.33
41 An administrative claims model for profiling hospital 30-day mortality rates for pneumonia patients. PLoS One 2011 2.22
42 Hospital volume and 30-day mortality for three common medical conditions. N Engl J Med 2010 2.20
43 The performance of US hospitals as reflected in risk-standardized 30-day mortality and readmission rates for medicare beneficiaries with pneumonia. J Hosp Med 2010 2.20
44 The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 3--valve plus coronary artery bypass grafting surgery. Ann Thorac Surg 2009 2.18
45 Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. Am J Med 2004 2.15
46 National trends in outcomes among elderly patients with heart failure. Am J Med 2006 2.13
47 ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). Circulation 2006 2.12
48 American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. Circulation 2005 2.10
49 Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med 2011 2.09
50 Relationship between hospital readmission and mortality rates for patients hospitalized with acute myocardial infarction, heart failure, or pneumonia. JAMA 2013 2.06
51 Rationale and design of the dual antiplatelet therapy study, a prospective, multicenter, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy in subjects undergoing percutaneous coronary intervention with either drug-eluting stent or bare metal stent placement for the treatment of coronary artery lesions. Am Heart J 2010 2.00
52 "America's Best Hospitals" in the treatment of acute myocardial infarction. Arch Intern Med 2007 1.96
53 Coronary artery spatial distribution of acute myocardial infarction occlusions. Circulation 2004 1.96
54 "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency. J Am Soc Nephrol 2004 1.94
55 Getting the methods right--the foundation of patient-centered outcomes research. N Engl J Med 2012 1.92
56 Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials. Biometrics 2005 1.91
57 Comparison of hospital risk-standardized mortality rates calculated by using in-hospital and 30-day models: an observational study with implications for hospital profiling. Ann Intern Med 2012 1.90
58 ACC/AHA Clinical Performance Measures for Adults with Chronic Heart Failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures): endorsed by the Heart Failure Society of America. Circulation 2005 1.90
59 Use of drug-eluting stents as a function of predicted benefit: clinical and economic implications of current practice. Arch Intern Med 2012 1.89
60 Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study. BMJ 2005 1.84
61 Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI dataset: a study from the Massachusetts Angioplasty Registry. J Am Coll Cardiol 2011 1.84
62 Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA 2010 1.83
63 Performance measurement in the small office practice: challenges and potential solutions. Ann Intern Med 2008 1.80
64 Longitudinal profiling of health care units based on continuous and discrete patient outcomes. Biostatistics 2005 1.79
65 Comparison of "risk-adjusted" hospital outcomes. Circulation 2008 1.78
66 ACC/AHA clinical performance measures for adults with chronic heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Heart Failure Clinical Performance Measures) endorsed by the Heart Failure Society of America. J Am Coll Cardiol 2005 1.76
67 The volume-outcome relationship: from Luft to Leapfrog. Ann Thorac Surg 2003 1.76
68 ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 2006 1.74
69 Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts. Circulation 2008 1.68
70 Atypical antipsychotics and parkinsonism. Arch Intern Med 2005 1.66
71 Comparative assessment of implantable hip devices with different bearing surfaces: systematic appraisal of evidence. BMJ 2011 1.63
72 Acute myocardial infarction and congestive heart failure outcomes at specialty cardiac hospitals. Circulation 2007 1.61
73 Implementation of a cardiac surgery report card: lessons from the Massachusetts experience. Ann Thorac Surg 2005 1.58
74 The medical treatment of depression, 1991-1996: productive inefficiency, expected outcome variations, and price indexes. J Health Econ 2002 1.55
75 Differences in patient survival after acute myocardial infarction by hospital capability of performing percutaneous coronary intervention: implications for regionalization. Arch Intern Med 2010 1.52
76 Association of single- vs dual-chamber ICDs with mortality, readmissions, and complications among patients receiving an ICD for primary prevention. JAMA 2013 1.51
77 Is same-hospital readmission rate a good surrogate for all-hospital readmission rate? Med Care 2010 1.51
78 Vascular closure device failure in contemporary practice. JACC Cardiovasc Interv 2012 1.50
79 Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences. Med Care 2006 1.50
80 Quality of care in the US territories. Arch Intern Med 2011 1.49
81 Long-term clinical outcomes following drug-eluting or bare-metal stent placement in patients with severely reduced GFR: Results of the Massachusetts Data Analysis Center (Mass-DAC) State Registry. Am J Kidney Dis 2010 1.46
82 Racial and ethnic service use disparities among homeless adults with severe mental illnesses receiving ACT. Psychiatr Serv 2011 1.43
83 Correlated bivariate continuous and binary outcomes: issues and applications. Stat Med 2009 1.43
84 Warfarin prescribing in atrial fibrillation: the impact of physician, patient, and hospital characteristics. Am J Med 2006 1.40
85 Drug-eluting stents versus bare metal stents prior to noncardiac surgery. Catheter Cardiovasc Interv 2014 1.39
86 Externally caused deaths for adults with substance use and mental disorders. J Behav Health Serv Res 2004 1.37
87 Intent-to-Treat vs. Non-Intent-to-Treat Analyses under Treatment Non-Adherence in Mental Health Randomized Trials. Psychiatr Ann 2008 1.36
88 Socioeconomic disparities in outcomes after acute myocardial infarction. Am Heart J 2007 1.36
89 The effects of mental health parity on spending and utilization for bipolar, major depression, and adjustment disorders. Am J Psychiatry 2013 1.34
90 Quality of care for the treatment of acute medical conditions in US hospitals. Arch Intern Med 2006 1.33
91 Impact of full mental health and substance abuse parity for children in the Federal Employees Health Benefits Program. Pediatrics 2007 1.33
92 Public reporting of 30-day mortality for patients hospitalized with acute myocardial infarction and heart failure. Circulation 2008 1.30
93 Low-volume coronary artery bypass surgery: measuring and optimizing performance. J Thorac Cardiovasc Surg 2008 1.29
94 Variation in hospital mortality rates for patients with acute myocardial infarction. Am J Cardiol 2010 1.28
95 Public reporting of cardiac surgery performance: Part 1--history, rationale, consequences. Ann Thorac Surg 2011 1.28
96 Does prospective payment reduce inpatient length of stay? Health Econ 2002 1.28
97 Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry 2010 1.27
98 Geographic disparities in the incidence and outcomes of hospitalized myocardial infarction: does a rising tide lift all boats? Circ Cardiovasc Qual Outcomes 2012 1.25
99 Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research and the American College of Cardiology Foundation. Circulation 2008 1.25
100 Quality of care for acute myocardial infarction at urban safety-net hospitals. Health Aff (Millwood) 2007 1.23
101 Postmarketing surveillance of medical devices--filling in the gaps. N Engl J Med 2012 1.23
102 Effect of insurance parity on substance abuse treatment. Psychiatr Serv 2011 1.23
103 Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood) 2012 1.23
104 Differential item functioning between ethnic groups in the epidemiological assessment of depression. J Nerv Ment Dis 2008 1.16
105 A prospective study of familial conflict, psychological stress, and the development of substance use disorders in adolescence. Drug Alcohol Depend 2009 1.16
106 Longitudinal profiles of health care providers. Stat Med 2002 1.16
107 Guideline recommendations for treatment of schizophrenia: the impact of managed care. Arch Gen Psychiatry 2003 1.16
108 Skilled nursing facility referral and hospital readmission rates after heart failure or myocardial infarction. Am J Med 2012 1.16
109 Association of hospital coronary artery bypass volume with processes of care, mortality, morbidity, and the Society of Thoracic Surgeons composite quality score. J Thorac Cardiovasc Surg 2009 1.15
110 Public reporting of cardiac surgery performance: Part 2--implementation. Ann Thorac Surg 2011 1.14
111 Process of care and outcome after acute myocardial infarction for patients with mental illness in the VA health care system: are there disparities? Health Serv Res 2003 1.14
112 Reducing asthma health disparities in poor Puerto Rican children: the effectiveness of a culturally tailored family intervention. J Allergy Clin Immunol 2007 1.13
113 Quality of care in Medicaid managed care and commercial health plans. JAMA 2007 1.13
114 Employers' use of value-based purchasing strategies. JAMA 2007 1.11
115 The impact of parity on major depression treatment quality in the Federal Employees' Health Benefits Program after parity implementation. Med Care 2006 1.09
116 A Bayesian model for repeated measures zero-inflated count data with application to outpatient psychiatric service use. Stat Modelling 2010 1.08
117 American College of Cardiology and American Heart Association methodology for the selection and creation of performance measures for quantifying the quality of cardiovascular care. J Am Coll Cardiol 2005 1.03
118 Understanding individual and small area variation in the underuse of coronary angiography following acute myocardial infarction. Med Care 2002 1.03
119 Gender differences in the association between family conflict and adolescent substance use disorders. J Adolesc Health 2011 1.02
120 A prediction model to identify patients at high risk for 30-day readmission after percutaneous coronary intervention. Circ Cardiovasc Qual Outcomes 2013 1.01
121 Using Non-experimental Data to Estimate Treatment Effects. Psychiatr Ann 2009 1.01
122 Sources of hospital variation in short-term readmission rates after percutaneous coronary intervention. Circ Cardiovasc Interv 2012 1.01
123 Predicting the restenosis benefit of drug-eluting versus bare metal stents in percutaneous coronary intervention. Circulation 2011 1.00
124 A framework for evidence evaluation and methodological issues in implantable device studies. Med Care 2010 0.99
125 A bayesian two-part latent class model for longitudinal medical expenditure data: assessing the impact of mental health and substance abuse parity. Biometrics 2011 0.99
126 Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry. Circulation 2008 0.98
127 Hospital remoteness and thirty-day mortality from three serious conditions. Health Aff (Millwood) 2008 0.98
128 Longitudinal racial/ethnic disparities in antimanic medication use in bipolar-I disorder. Med Care 2009 0.98
129 Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief report. J Clin Psychiatry 2010 0.98
130 Postmarket surveillance for medical devices: America's new strategy. BMJ 2012 0.97
131 Selection and plan switching behavior. Inquiry 2006 0.97
132 A comparison of methods for combining quality and efficiency performance measures: profiling the value of hospital care following acute myocardial infarction. Stat Med 2008 0.97
133 Post-acute service use following acute myocardial infarction in the elderly. Health Care Financ Rev 2002 0.96
134 Quality monitoring and management in commercial health plans. Am J Manag Care 2008 0.96
135 Statistical methodology for classifying units on the basis of multiple-related measures. Stat Med 2008 0.96
136 Investigation of racial and ethnic disparities in service utilization among homeless adults with severe mental illnesses. Psychiatr Serv 2009 0.95
137 Mortality and readmission for patients with heart failure among U.S. News & World Report's top heart hospitals. Circ Cardiovasc Qual Outcomes 2009 0.94
138 Alternative methods for testing treatment effects on the basis of multiple outcomes: simulation and case study. Stat Med 2011 0.93
139 On the use of discrete choice models for causal inference. Stat Med 2005 0.93
140 Incentive formularies and changes in prescription drug spending. Am J Manag Care 2007 0.93
141 Balancing Treatment Comparisons in Longitudinal Studies. Psychiatr Ann 2008 0.93
142 Hospital-wide mortality as a quality metric: conceptual and methodological challenges. Am J Med Qual 2011 0.92
143 Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005. Psychiatr Serv 2012 0.91
144 Improving quality and diffusing best practices: the case of schizophrenia. Health Aff (Millwood) 2009 0.91
145 Hospital patterns of use of positive inotropic agents in patients with heart failure. J Am Coll Cardiol 2012 0.90
146 Sample Size Determination for Studies with Repeated Continuous Outcomes. Psychiatr Ann 2008 0.90
147 ACCF/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures. Circulation 2010 0.89
148 ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2012 0.89
149 The use and abuse of multiple outcomes in randomized controlled depression trials. Contemp Clin Trials 2010 0.89
150 Causes of short-term readmission after percutaneous coronary intervention. Circ Cardiovasc Interv 2014 0.88
151 Standards for measures used for public reporting of efficiency in health care: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes research and the American College of Cardiology Foundation. J Am Coll Cardiol 2008 0.88
152 Improving traditional intention-to-treat analyses: a new approach. Psychol Med 2005 0.88
153 Hospital teaching intensity and mortality for acute myocardial infarction, heart failure, and pneumonia. Med Care 2014 0.88
154 A cost-effectiveness framework for profiling the value of hospital care. Med Decis Making 2008 0.87
155 Characteristics of medical practices in three developed managed care markets. Health Serv Res 2005 0.87
156 Antidepressant reformulations: who uses them, and what are the benefits? Health Aff (Millwood) 2009 0.86
157 Cardiology patient pages. How are our hospitals measuring up?: "hospital compare": a resource for hospital quality of care. Circulation 2008 0.86
158 Evaluation of an automated safety surveillance system using risk adjusted sequential probability ratio testing. BMC Med Inform Decis Mak 2011 0.86
159 Bivalirudin therapy is associated with improved clinical and economic outcomes in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: results from an observational database. Circ Cardiovasc Qual Outcomes 2012 0.85
160 Regional density of cardiologists and rates of mortality for acute myocardial infarction and heart failure. Circ Cardiovasc Qual Outcomes 2013 0.85
161 Ten-year trends in quality of care and spending for depression: 1996 through 2005. Arch Gen Psychiatry 2011 0.84
162 Evaluating the optimal timing of angiography: landmark or off the mark? Circulation 2007 0.84
163 Sample size calculation for a historically controlled clinical trial with adjustment for covariates. J Biopharm Stat 2002 0.83
164 Older men with dementia are at greater risk than women of serious events after initiating antipsychotic therapy. J Am Geriatr Soc 2013 0.83
165 Comparison of self-report and clinician-rated measures of psychiatric symptoms and functioning in predicting 1-year hospital readmission. Adm Policy Ment Health 2006 0.83
166 A meta-analysis of labor supply effects of interventions for major depressive disorder. Psychiatr Serv 2006 0.83
167 Thirty-day outcomes in Medicare patients with heart failure at heart transplant centers. Circ Heart Fail 2010 0.83
168 Covariate adjustment in clinical trials with non-ignorable missing data and non-compliance. Stat Med 2004 0.82
169 Impact of independent data adjudication on hospital-specific estimates of risk-adjusted mortality following percutaneous coronary interventions in massachusetts. Circ Cardiovasc Qual Outcomes 2010 0.82
170 Using Multiple Control Groups and Matching to Address Unobserved Biases in Comparative Effectiveness Research: An Observational Study of the Effectiveness of Mental Health Parity. Stat Biosci 2011 0.82
171 Economic grand rounds: the price is right? Changes in the quantity of services used and prices paid in response to parity. Psychiatr Serv 2012 0.82
172 Bipolar-I patient characteristics associated with differences in antimanic medication prescribing. Psychopharmacol Bull 2009 0.81
173 Contemporary performance of U.S. teaching and nonteaching hospitals. Acad Med 2012 0.81
174 On the accuracy of classifying hospitals on their performance measures. Stat Med 2013 0.81
175 Instrumental variable analysis to compare effectiveness of stents in the extremely elderly. Circ Cardiovasc Qual Outcomes 2013 0.81
176 Impact of cardiac service availability on case-selection for angiography and survival associated with angiography. Health Serv Res 2003 0.81
177 Studies of drug-eluting stents: to each his own? Circulation 2008 0.81
178 Engagement of health plans and employers in addressing racial and ethnic disparities in health care. Med Care Res Rev 2008 0.81
179 Measuring hospital clinical outcomes. BMJ 2013 0.81
180 Cancer Rates in Adults After Cardiac Interventions: A Preliminary Observational Report. Am J Clin Oncol 2017 0.80
181 Managed mental health care's effects on arrest and forensic commitment. Int J Law Psychiatry 2004 0.80
182 "Usual care" for major depression in the 1990s: characteristics and expert-estimated outcomes. Am J Psychiatry 2003 0.80
183 "Phenotyping" hospital value of care for patients with heart failure. Health Serv Res 2014 0.80
184 Effects of gender and ethnicity on outcomes after aortic valve replacement. J Thorac Cardiovasc Surg 2011 0.79
185 Use of administrative claims models to assess 30-day mortality among Veterans Health Administration hospitals. Med Care 2010 0.79
186 Protocol for the China PEACE (Patient-centered Evaluative Assessment of Cardiac Events) retrospective study of coronary catheterisation and percutaneous coronary intervention. BMJ Open 2014 0.79
187 Measuring percutaneous coronary intervention quality by simple case volume. Circulation 2005 0.79
188 Accurately predicting bipolar disorder mood outcomes: implications for the use of electronic databases. Med Care 2012 0.79
189 The effect of race-ethnicity and geography on adoption of innovations in the treatment of schizophrenia. Psychiatr Serv 2012 0.79
190 Registry studies for improving the quality of cardiovascular care: the role of variance components. Circ Cardiovasc Qual Outcomes 2012 0.78
191 Limiting inpatient substance use treatment: what are the consequences? Med Care Res Rev 2003 0.78
192 Comparative effectiveness research: does one size fit all? Stat Med 2012 0.78
193 Disparities in quality of care among publicly insured adults with schizophrenia in four large U.S. states, 2002-2008. Health Serv Res 2014 0.78
194 ACCF/AHA new insights into the methodology of performance measurement: a report of the American College of Cardiology Foundation/American Heart Association Task Force on performance measures. J Am Coll Cardiol 2010 0.78
195 The effect of race-ethnicity on the comparative effectiveness of clozapine among Medicaid beneficiaries. Psychiatr Serv 2013 0.78
196 Parity and out-of-pocket spending for children with high mental health or substance abuse expenditures. Pediatrics 2013 0.77
197 Regional associations between Medicare Advantage penetration and administrative claims-based measures of hospital outcomes. Med Care 2012 0.77
198 Coronary artery bypass graft: contemporary heart surgery center performance in China. Circ Cardiovasc Qual Outcomes 2012 0.77
199 Composite measures for hospital quality using quality-adjusted life years. Stat Med 2009 0.77
200 Racial and ethnic disparities in access to higher and lower quality cardiac surgeons for coronary artery bypass grafting. Am J Cardiol 2009 0.77
201 ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2012 0.77
202 Thirty-Day Hospital Readmission for Medicaid Enrollees with Schizophrenia: The Role of Local Health Care Systems. J Ment Health Policy Econ 2015 0.75
203 Myocardial infarction and quality of care. CMAJ 2008 0.75
204 PCI at hospitals with or without on-site cardiac surgery. N Engl J Med 2013 0.75
205 Hospital Phenotypes in the Management of Patients Admitted for Acute Myocardial Infarction. Med Care 2016 0.75
206 Response to letters regarding article, "Bayesian methods affirm the use of percutaneous coronary intervention to improve survival in patients with unprotected left main coronary artery disease". Circulation 2014 0.75
207 Autonomy, beneficence, justice, and the limits of provider profiling. J Am Coll Cardiol 2012 0.75
208 Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures. J Ment Health Policy Econ 2016 0.75
209 Mitigating the Problem of Unmeasured Outcomes in Quality Reports. B E J Econom Anal Policy 2008 0.75
210 Use of a state inpatient forensic system under managed mental health care. Psychiatr Serv 2002 0.75
211 Comparing teaching versus nonteaching hospitals: the association of patient characteristics with teaching intensity for three common medical conditions. Acad Med 2014 0.75
212 Comments on 'The BUGS project: Evolution, critique, and future directions'. Stat Med 2009 0.75
213 Quality of Care in the United States Territories, 1999-2012. Med Care 2017 0.75
214 Rationale and design of the MASS COMM trial: A randomized trial to compare percutaneous coronary intervention between MASSachusetts hospitals with cardiac surgery on-site and COMMunity hospitals without cardiac surgery on-site. Am Heart J 2011 0.75
215 Toward a model for testing the relationship between quality of care and costs. J Ment Health Policy Econ 2004 0.75
216 Application of models for multivariate mixed outcomes to medical device trials: coronary artery stenting. Stat Med 2003 0.75
217 Continuing medical education program in the journal of hospital medicine. J Hosp Med 2011 0.75
218 Quality of Care in the United States Territories, 1999-2012. Med Care 2017 0.75
219 Rating the Raters: The Inconsistent Quality of Health Care Performance Measurement. Ann Surg 2016 0.75